Please use this identifier to cite or link to this item:
Title: Nanotechnology approaches in the current therapy of skin cancer
Author: Borgheti Cardoso, Livia Neves
Viegas, Juliana Santos Rosa
Silvestrini, Ana Vitoria Pupo
Caron, Angelo Luis
Praça, Fabiola Garcia
Kravicz, Marcelo
Lopes Badra Bentley, Maria Vitória
Keywords: Càncer de pell
Skin cancer
Issue Date: 27-Feb-2020
Publisher: Elsevier
Abstract: Skin cancer is a high burden disease with a high impact on global health. Conventional therapies have several drawbacks; thus, the development of effective therapies is required. In this context, nanotechnology approaches are an attractive strategy for cancer therapy because they enable the efficient delivery of drugs and other bioactive molecules to target tissues with low toxic effects. In this review, nanotechnological tools for skin cancer will be summarized and discussed. First, pathology and conventional therapies will be presented, followed by the challenges of skin cancer therapy. Then, the main features of developing efficient nanosystems will be discussed, and next, the most commonly used nanoparticles (NPs) described in the literature for skin cancer therapy will be presented. Subsequently, the use of NPs to deliver chemotherapeutics, immune and vaccine molecules and nucleic acids will be reviewed and discussed as will the combination of physical methods and NPs. Finally, multifunctional delivery systems to codeliver anticancer therapeutic agents containing or not surface functionalization will be summarized.
Note: Versió postprint del document publicat a:
It is part of: Advanced Drug Delivery Reviews, 2020
Related resource:
ISSN: 0169-409X
Appears in Collections:Articles publicats en revistes (Institut de Bioenginyeria de Catalunya (IBEC))
Articles publicats en revistes (ISGlobal)

Files in This Item:
File Description SizeFormat 
Borgheti-Cardoso_L_N_Avd_Drug_Deliv_Rev_2020.pdf2.87 MBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons